Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agios Pharmaceuticals Inc | 3.1B | 4.5x | --- |
Bio-Techne Corp | 10.9B | 75.6x | +11.13% |
Biogen Inc | 22.7B | 14.3x | -18.14% |
Charles River Laboratories International Inc | 9.6B | 24.2x | +15.57% |
Genmab A/S | 13.6B | 20.3x | +22.71% |
Grifols SA | 7.0B | 36.6x | --- |
ICON PLC | 16.8B | 23.7x | +4.68% |
Incyte Corp | 13.7B | 503.0x | +39.11% |
IQVIA Holdings Inc | 35.3B | 25.9x | +46.62% |
Medpace Holdings Inc | 10.1B | 29.9x | +35.10% |
Qiagen NV | 9.4B | 103.8x | +12.66% |
Regeneron Pharmaceuticals Inc | 81.7B | 18.4x | +10.93% |
United Therapeutics Corp | 16.3B | 16.1x | +8.22% |
ABPRO Holdings Inc | 27.4M | 22.8x | --- |
ACADIA Pharmaceuticals Inc | 2.7B | 20.9x | --- |
ADMA Biologics Inc | 5.1B | 77.1x | --- |
Alkermes Plc | 4.5B | 9.4x | --- |
BioMarin Pharmaceutical Inc | 11.9B | 38.2x | --- |
Catalyst Pharmaceuticals Inc | 2.5B | 18.0x | --- |
Chromadex Corp | 572.9M | 403.1x | --- |
Citius Oncology Inc | 70.6M | 4.0x | --- |
Compugen Ltd | 128.0M | 75.6x | --- |
CureVac NV | 558.5M | 5.1x | --- |
CytomX Therapeutics Inc | 68.1M | 5.2x | --- |
Dynavax Technologies Corp | 1.6B | 101.3x | --- |
Entrada Therapeutics Inc | 670.9M | 11.3x | --- |
Enzon Pharmaceuticals Inc | 5.3M | 21.4x | -60.21% |
Exelixis Inc | 9.9B | 22.2x | -21.77% |
Halberd Corp | 2.5M | 1.6x | --- |
Kamada Ltd | 334.6M | 18.9x | -22.48% |
Kiora Pharmaceuticals Inc | 10.3M | -5.5x | --- |
Krystal Biotech Inc | 5.1B | 103.1x | --- |
MannKind Corp | 1.9B | 97.0x | --- |
MiMedx Group Inc | 1.3B | 18.6x | --- |
Neurocrine Biosciences Inc | 12.5B | 33.5x | +62.04% |
Nutra Pharma Corp | 759.7K | 0.2x | --- |
Oramed Pharmaceuticals Inc | 91.1M | 23.1x | --- |
PharmaCyte Biotech Inc | 13.2M | 3.5x | --- |
Precision BioSciences Inc | 55.1M | 8.5x | --- |
Protagonist Therapeutics Inc | 2.4B | 15.6x | --- |
Sarepta Therapeutics Inc | 10.6B | 90.9x | --- |
Seelos Therapeutics Inc | 170.0K | 0.0x | --- |
Spero Therapeutics Inc | 64.9M | 19.5x | --- |
Tevogen Bio Holdings Inc | 242.3M | 4.4x | --- |
TRACON Pharmaceuticals Inc | 102.2K | 0.0x | --- |
Vericel Corp | 2.8B | 733.1x | --- |
Viaderma Inc | 11.7M | 0.0x | --- |
Voyager Therapeutics Inc | 292.3M | 9.2x | --- |
2Seventy Bio Inc | 160.2M | -1.7x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
| Company | Dividend Yield |
|---|---|
Enzo Biochem Inc | 10.13% |
BIO-TECHNE Corp | 0.47% |
Avid Bioservices Inc | --- |
XOMA Royalty Corp | --- |
Alkermes Plc | --- |